Zivo Bioscience, Inc.
ZIVO
$6.96
-$2.54-26.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 209.00K | 174.90K | 121.50K | 157.20K | 79.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 209.00K | 174.90K | 121.50K | 157.20K | 79.00K |
| Cost of Revenue | 142.80K | 120.60K | 85.10K | 108.30K | 53.00K |
| Gross Profit | 66.20K | 54.40K | 36.50K | 49.00K | 26.10K |
| SG&A Expenses | 4.83M | 5.93M | 10.74M | 10.28M | 10.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.67M | 9.87M | 16.42M | 13.52M | 13.74M |
| Operating Income | -8.46M | -9.70M | -16.29M | -13.36M | -13.66M |
| Income Before Tax | -8.49M | -9.72M | -16.32M | -13.38M | -13.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.49 | -9.72 | -16.32 | -13.38 | -13.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.49M | -9.72M | -16.32M | -13.38M | -13.69M |
| EBIT | -8.46M | -9.70M | -16.29M | -13.36M | -13.66M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -2.28 | -2.67 | -5.02 | -4.36 | -4.90 |
| Normalized Basic EPS | -1.42 | -1.67 | -3.14 | -2.73 | -3.06 |
| EPS Diluted | -2.28 | -2.67 | -5.02 | -4.36 | -4.90 |
| Normalized Diluted EPS | -1.42 | -1.67 | -3.14 | -2.73 | -3.06 |
| Average Basic Shares Outstanding | 14.92M | 14.51M | 13.67M | 12.66M | 11.05M |
| Average Diluted Shares Outstanding | 14.92M | 14.51M | 13.67M | 12.66M | 11.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |